TipRanks

Katherine Stueland Insider Profile

11 Followers
Katherine Stueland, CEO, Director at GeneDx Holdings, holds 107.23K shares in GeneDx Holdings (Ticker: WGS), holds 214.23K shares in Invitae (Ticker: NVTAQ).
tipranks
Katherine Stueland

Katherine Stueland
GeneDx Holdings (WGS)
CEO, Director

Ranked #106,704 out of 109,030 Corporate Insiders

Profitable Transactions

38%
6 out of 16 Profitable Transactions

Average Return

-95.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$10M
100.00%
A breakdown of Katherine Stueland's holdings

Insider Roles

GeneDx Holdings
(WGS)
CEO, Director
Roles that Katherine Stueland holds in companies

Most Profitable Insider Trade

Stock:
Invitae
(NVTAQ)
Rating:Informative Sell
Date:Jun 16, 2021 - Jun 16, 2022
Return:+92.90%
The most profitable trade made by Katherine Stueland

Katherine Stueland's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
GeneDx Holdings
Sep 11, 2026
CEO, Director
Uninformative Buy
240.42K
$10.15M
NVTAQ
Invitae
Jun 16, 2021
Uninformative Sell
363.24K
$2.36K
List of latest transactions for each holding click on a transaction to see Katherine Stueland's performance on stock

Katherine Stueland insider profile FAQ

What is the percentage of profitable transactions made by Katherine Stueland?
The percentage of profitable transactions made by Katherine Stueland is 38%.
    What is the average return per transaction made by Katherine Stueland?
    The average return per transaction made by Katherine Stueland is -95.30%.
      What stocks does Katherine Stueland hold?
      Katherine Stueland holds: WGS, NVTAQ stocks.
        What was Katherine Stueland’s latest transaction?
        Katherine Stueland latest transaction was an Uninformative Buy of $240.42K.
          What was Katherine Stueland's most profitable transaction?
          Katherine Stueland’s most profitable transaction was an Informative Sell of NVTAQ stock on June 16, 2021. The return on the trade was 92.90%.
            What is Katherine Stueland's role in GeneDx Holdings?
            Katherine Stueland's role in GeneDx Holdings is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.